DBV Technologies (DBVT) Revenue (2020 - 2026)
DBV Technologies (DBVT) posted Revenue of $700000.0 for Q2 2026, down 22.22% sequentially from $900000.0 in Q1 2026, and down 53.33% YoY from $1.5 million in Q2 2025.
DBV Technologies (DBVT) Revenue (2020 - 2026) Analysis & Trends
DBV Technologies has reported Revenue for 7 years, with the latest figure at $700000.0 in Q2 2026.
- Quarterly Revenue fell 53.33% year-over-year to $700000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.0 million (up 27.64% YoY) and the FY2025 annual result came in at $5.6 million, up 34.19% from the prior year.
- Revenue retreated to $700000.0 in Q2 2026 per DBVT's latest filing, from $900000.0 in the prior quarter.
- Over five years, Revenue peaked at $8.9 million in Q4 2023 and troughed at -$1.3 million in Q4 2022.
- A 5-year average of $1.8 million and a median of $1.5 million in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue sank 144.47% in 2022, then surged 780.6% in 2023.
- Over 5 years, Revenue stood at -$1.3 million in 2022, then soared by 780.6% to $8.9 million in 2023, then slumped by 93.69% to $560000.0 in 2024, then advanced by 15.18% to $645000.0 in 2025, then increased by 8.53% to $700000.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $700000.0, $900000.0, and $645000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 645,000.00 |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 560,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | -1.30 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 1.32 Mn |